Cargando…

Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration

Anti-angiogenesis has been proposed as an effective therapeutic strategy for cancer treatment. Pigment epithelium-derived factor (PEDF) is one of the most powerful endogenous anti-angiogenic reagents discovered to date and PEDF gene therapy has been recognized as a promising treatment option for var...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ting, Xu, Bei, He, Lili, Xia, Shan, Chen, Yan, Zeng, Jun, Liu, Yongmei, Li, Shuangzhi, Tan, Xiaoyue, Ren, Ke, Yao, Shaohua, Song, Xiangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772918/
https://www.ncbi.nlm.nih.gov/pubmed/26955272
http://dx.doi.org/10.2147/IJN.S97223
_version_ 1782418640324263936
author Yu, Ting
Xu, Bei
He, Lili
Xia, Shan
Chen, Yan
Zeng, Jun
Liu, Yongmei
Li, Shuangzhi
Tan, Xiaoyue
Ren, Ke
Yao, Shaohua
Song, Xiangrong
author_facet Yu, Ting
Xu, Bei
He, Lili
Xia, Shan
Chen, Yan
Zeng, Jun
Liu, Yongmei
Li, Shuangzhi
Tan, Xiaoyue
Ren, Ke
Yao, Shaohua
Song, Xiangrong
author_sort Yu, Ting
collection PubMed
description Anti-angiogenesis has been proposed as an effective therapeutic strategy for cancer treatment. Pigment epithelium-derived factor (PEDF) is one of the most powerful endogenous anti-angiogenic reagents discovered to date and PEDF gene therapy has been recognized as a promising treatment option for various tumors. There is an urgent need to develop a safe and valid vector for its systemic delivery. Herein, a novel gene delivery system based on the newly synthesized copolymer COOH-PEG-PLGA-COOH (CPPC) was developed in this study, which was probably capable of overcoming the disadvantages of viral vectors and cationic lipids/polymers-based nonviral carriers. PEDF gene loaded CPPC nanoparticles (D-NPs) were fabricated by a modified double-emulsion water-in-oil-in-water (W/O/W) solvent evaporation method. D-NPs with uniform spherical shape had relatively high drug loading (~1.6%), probably because the introduced carboxyl group in poly (D,L-lactide-co-glycolide) terminal enhanced the interaction of copolymer with the PEDF gene complexes. An excellent in vitro antitumor effect was found in both C26 and A549 cells treated by D-NPs, in which PEDF levels were dramatically elevated due to the successful transfection of PEDF gene. D-NPs also showed a strong inhibitory effect on proliferation of human umbilical vein endothelial cells in vitro and inhibited the tumor-induced angiogenesis in vivo by an alginate-encapsulated tumor cell assay. Further in vivo antitumor investigation, carried out in a C26 subcutaneous tumor model by intravenous injection, demonstrated that D-NPs could achieve a significant antitumor activity with sharply reduced microvessel density and significantly promoted tumor cell apoptosis. Additionally, the in vitro hemolysis analysis and in vivo serological and biochemical analysis revealed that D-NPs had no obvious toxicity. All the data indicated that the novel CPPC nanoparticles were ideal vectors for the systemic delivery of PEDF gene and might be widely used as systemic gene vectors.
format Online
Article
Text
id pubmed-4772918
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47729182016-03-07 Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration Yu, Ting Xu, Bei He, Lili Xia, Shan Chen, Yan Zeng, Jun Liu, Yongmei Li, Shuangzhi Tan, Xiaoyue Ren, Ke Yao, Shaohua Song, Xiangrong Int J Nanomedicine Original Research Anti-angiogenesis has been proposed as an effective therapeutic strategy for cancer treatment. Pigment epithelium-derived factor (PEDF) is one of the most powerful endogenous anti-angiogenic reagents discovered to date and PEDF gene therapy has been recognized as a promising treatment option for various tumors. There is an urgent need to develop a safe and valid vector for its systemic delivery. Herein, a novel gene delivery system based on the newly synthesized copolymer COOH-PEG-PLGA-COOH (CPPC) was developed in this study, which was probably capable of overcoming the disadvantages of viral vectors and cationic lipids/polymers-based nonviral carriers. PEDF gene loaded CPPC nanoparticles (D-NPs) were fabricated by a modified double-emulsion water-in-oil-in-water (W/O/W) solvent evaporation method. D-NPs with uniform spherical shape had relatively high drug loading (~1.6%), probably because the introduced carboxyl group in poly (D,L-lactide-co-glycolide) terminal enhanced the interaction of copolymer with the PEDF gene complexes. An excellent in vitro antitumor effect was found in both C26 and A549 cells treated by D-NPs, in which PEDF levels were dramatically elevated due to the successful transfection of PEDF gene. D-NPs also showed a strong inhibitory effect on proliferation of human umbilical vein endothelial cells in vitro and inhibited the tumor-induced angiogenesis in vivo by an alginate-encapsulated tumor cell assay. Further in vivo antitumor investigation, carried out in a C26 subcutaneous tumor model by intravenous injection, demonstrated that D-NPs could achieve a significant antitumor activity with sharply reduced microvessel density and significantly promoted tumor cell apoptosis. Additionally, the in vitro hemolysis analysis and in vivo serological and biochemical analysis revealed that D-NPs had no obvious toxicity. All the data indicated that the novel CPPC nanoparticles were ideal vectors for the systemic delivery of PEDF gene and might be widely used as systemic gene vectors. Dove Medical Press 2016-02-25 /pmc/articles/PMC4772918/ /pubmed/26955272 http://dx.doi.org/10.2147/IJN.S97223 Text en © 2016 Yu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Yu, Ting
Xu, Bei
He, Lili
Xia, Shan
Chen, Yan
Zeng, Jun
Liu, Yongmei
Li, Shuangzhi
Tan, Xiaoyue
Ren, Ke
Yao, Shaohua
Song, Xiangrong
Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration
title Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration
title_full Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration
title_fullStr Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration
title_full_unstemmed Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration
title_short Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration
title_sort pigment epithelial-derived factor gene loaded novel cooh-peg-plga-cooh nanoparticles promoted tumor suppression by systemic administration
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772918/
https://www.ncbi.nlm.nih.gov/pubmed/26955272
http://dx.doi.org/10.2147/IJN.S97223
work_keys_str_mv AT yuting pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT xubei pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT helili pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT xiashan pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT chenyan pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT zengjun pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT liuyongmei pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT lishuangzhi pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT tanxiaoyue pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT renke pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT yaoshaohua pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration
AT songxiangrong pigmentepithelialderivedfactorgeneloadednovelcoohpegplgacoohnanoparticlespromotedtumorsuppressionbysystemicadministration